Primmune Therapeutics Inc
Primmune Therapeutics Inc., located in Carlsbad, CA, is dedicated to harnessing innate immunity to improve cancer treatment outcomes. Founded by experts in drug design and pharmacology, the company focuses on activating plasmacytoid dendritic cells via the TLR7 pathway, particularly through its lead candidate, PRTX007.
PRTX007 is designed to activate key components of the immune response while minimizing pro-inflammatory factors, enabling a well-tolerated and sustained immune activation. The company is advancing PRTX007 towards clinical trials, specifically targeting HPV-caused oropharyngeal cancers and hepatocellular carcinoma, addressing significant unmet medical needs in oncology.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.